Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2008
04/10/2008US20080085537 Expression vector comprising nucleotide sequences coding multicistronic transcription unit and selectable marker polypeptide under translational control of a down stream internal ribosome entry site (IRES) for use in enhancement of heterologous gene expression
04/10/2008US20080085536 Production of Cellulose in Halophilic Photosynthetic Prokaryotes (Cyanobacteria)
04/10/2008US20080085535 Using gene transfer construct comprising site specific integration sites as tool in enhancement of cell transformation and heterologous gene expression
04/10/2008US20080085531 Antagonistic anti-human CD40 monoclonal antibody
04/10/2008US20080085510 Human ron-related gene variant associated with cancers
04/10/2008US20080085277 Novel antigen-binding polypeptides and their uses
04/10/2008US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc
04/10/2008CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
04/10/2008CA2665269A1 Antibacterial and antiviral peptides from actinomadura namibiensis
04/10/2008CA2664738A1 Compositions and methods for diagnosing and treating cancer
04/09/2008EP1908837A2 Human receptor proteins, related reagents and methods
04/09/2008EP1908836A1 Novel G protein-coupled receptor proteins
04/09/2008EP1908825A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
04/09/2008EP1908774A1 Antibacterial and antiviral peptides from Actinomadura namibiensis
04/09/2008EP1908772A2 Porphorymonas gingivalis polypeptides and polynucleotides
04/09/2008EP1908770A1 Methods for preparing purified lipopeptides
04/09/2008EP1908769A1 A system for antibody expression and assembly
04/09/2008EP1908479A2 Anti-p53 Antibodies
04/09/2008EP1908478A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
04/09/2008EP1908354A1 Process for production of fermented milk and fermented milk beverage/food
04/09/2008EP1907854A2 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
04/09/2008EP1907610A2 Secretion of antibodies without signal peptides from bacteria
04/09/2008EP1907561A2 Cell lines for expressing enzyme useful in the preparation of amidated products
04/09/2008EP1907426A2 Novel anti-igf-ir antibodies and uses thereof
04/09/2008EP1907419A1 Preparation of insulin conjugates
04/09/2008EP1907412A2 Peptides inhibiting angiotensin-converting enzyme
04/09/2008EP1907002A2 Methods of treating autoimmune disease using humanized anti-cd16a antibodies
04/09/2008EP1716244A4 H. pylori fucosyltransferases
04/09/2008EP1680437A4 Motoneuronotrophic factor gene sequences
04/09/2008EP1420032B1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody
04/09/2008EP1394261A4 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
04/09/2008EP1280540B1 Modified factor viii
04/09/2008EP1036175B1 Human brain derived kcnq2 potassium channel
04/09/2008EP1027440B1 Inhibitor protein of the wnt signal pathway
04/09/2008EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof
04/09/2008EP0971958B1 Method for purifying factor viii/vwf complex by cation-exchange chromatography
04/09/2008EP0689587B1 Mutant luciferases
04/09/2008CN101160525A 非天然活性氨基酸遗传密码增加 Non-natural amino acid genetic code to increase activity
04/09/2008CN101157949A Fermentation amplification technique of engineering bacterium for producing anti-cancer drug TAT(m)-Survivin(T34A)
04/09/2008CN101157930A Fermentation process using specific oxygen uptake rates as a process control
04/09/2008CN101157728A ERK2 combination polypeptide and preparation thereof
04/09/2008CN100379875C Process for producing a-glycosylated dipeptide and method of assaying a-glycosylated dipeptide
04/09/2008CN100379874C Method for producing antibiotic peptide by using Bacillus amyloliquefaciens and product thereof
04/09/2008CN100379870C Cold-induced expression vector
04/09/2008CN100379868C Novel peptide synthase gene
04/09/2008CN100379863C Method of preparing natural human thymosin alpha 1 using series expression mode
04/09/2008CN100379862C Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
04/09/2008CN100379857C Chimeric animal and method for constructing the same
04/09/2008CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions
04/09/2008CN100379758C Streptococcus pneumoniae antigens
04/08/2008US7355092 Lower cost passive immunization; promoting expression of fimbrial antigens
04/08/2008US7355036 Two-stage protective groups for the synthesis of biopolymers
04/08/2008US7355032 Genes coding for metabolic pathway proteins
04/08/2008US7355031 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids
04/08/2008US7355030 Genes encoding carbon metabolism and energy-producing proteins
04/08/2008US7355029 Genes encoding carbon metabolism and energy-producing proteins
04/08/2008US7355028 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins)
04/08/2008US7355025 Marker molecules associated with lung tumors
04/08/2008US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins
04/08/2008US7355018 human insulin-like growth factor-1 fusion polypeptide that includes a component capable of forming a multimer with another modified IGF-1 fusion polypeptide; useful for treating a muscle-related disease or condition, such as muscle atrophy
04/08/2008US7355016 Methods for detection of mycobacteria
04/08/2008US7355015 Matriptase, a serine protease and its applications
04/08/2008US7355014 Monoclonal antibody used to purify the interferon-gamma inducing polypeptide; antitumor agents
04/08/2008US7355013 PRO6017 antibodies
04/08/2008US7355011 Comprises chimeric antibodies for diagnosis and treatment of lymphomas; antitumor agents
04/08/2008US7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same
04/08/2008US7355007 Antibodies that bind PRO5005 Polypeptides
04/08/2008US7355006 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/08/2008US7355003 Insecticidal protein for use as tool in preventing and controlling corn root worm infestation; biological pest control
04/08/2008US7355001 Diagnostic marker for diseases associated with the liver, pancreas , immunological system (thymus failure), reproduction, digestive system, skin, central nervous system, spleen, respiratory system, and thyroid hormone, and diabetes, hypertension, cancer, reperfusion injury following ischemia, retinitis
04/08/2008US7354999 PRO1481 polypeptides
04/08/2008US7354998 PRO7171 polypeptides
04/08/2008US7354994 Recombinant IGF expression systems
04/08/2008US7354901 Production of recombinant BMP-2
04/08/2008US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma
04/08/2008US7354761 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
04/08/2008US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening
04/08/2008US7354754 Mutant Rhodococcus with higher selectivity at low concentration than wild-type; causes cell lysis to recover recombinant protein
04/08/2008US7354752 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
04/08/2008US7354751 Alcohol dehydrogenase gene of acetic acid bacterium
04/08/2008US7354746 Method for producing optically active IHOG and monatin
04/08/2008US7354741 transferring N-acetylgalactosamine and N-acetylglucosamine using soluble protein; DNA can be used as probe for hybridization
04/08/2008US7354740 Animal product free system and process for purifying a botulinum toxin
04/08/2008US7354739 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide
04/08/2008US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation
04/08/2008US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy
04/08/2008US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders
04/08/2008US7354735 Green fluorescent protein; activation by caspase or protease; determining change in the degree of fluorescence resonance energy transfer
04/08/2008US7354734 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides;
04/08/2008US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
04/08/2008US7354594 Merozoite surface protein 1 lacking glycosylation sites
04/08/2008US7354586 Treating arthritis by administering a therapeutically effective amount of an antibody immunospecific for av beta 3; antiarthritic agents;anticarcinogenic agents; antitumor agents; antimetastasis agents; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3
04/08/2008US7354585 Methods of treating coagulapathic or thrombotic disorders
04/08/2008US7354583 Antibody-induced apoptosis
04/08/2008US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
04/08/2008CA2305013C Fusion proteins comprising hiv-1 tat and/or nef proteins
04/08/2008CA2253838C Dp and e2f protein nuclear localisation signals and their use
04/08/2008CA2205082C Method of forming double stranded dna polymer having repeating subunits in tandem
04/08/2008CA2169171C New growth/differentiation factor of the tgf-beta family
04/08/2008CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein